{
  "docId": "019dd923-622c-750b-8b99-9ee2a1e788fb",
  "docSlug": "1233d0b05ad9",
  "documentTitle": "PROCEPT BioRobotics Corporation (PRCT)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-16 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 72,
  "pageCount": 100,
  "prevPage": 71,
  "nextPage": 73,
  "slideType": "preempt_rebuttal",
  "function": "preempt_rebuttal",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses an orange analogy to explain the anatomical mismatch of the technology.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-9ee2a1e788fb/72",
  "deckHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb#slide-72",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "I think from a logical perspective, it does not make sense to use Aquablation for prostate cancer or focal therapy for prostate cancer.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929b-87a4be950aad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.38,
        "x": 0.02,
        "y": 0.82
      },
      "kind": "image",
      "text": "EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbd31db0-14e0-4ee6-b5bd-1b795eaeb5dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "Simplistically, if one thinks of the prostate as an orange, BPH resective procedures remove the core, or fruit, of the organ. However, most prostate cancer occurs on the peel or rind, the outside of the prostate. As a result, we believe a waterjet is simply a less effective tool for addressing that part of the prostate. If anything, we see traditional suppliers of focal therapy solutions for prostate cancer expanding into the BPH market.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23b12261-5fcf-487b-b7ea-df4c54f7408f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.57,
        "x": 0.41,
        "y": 0.86
      },
      "kind": "paragraph",
      "text": "Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fc665644-30ac-4e70-9793-a9359294df94",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.74,
        "x": 0.25,
        "y": 0.35
      },
      "kind": "quote",
      "text": "I think it's tricky with their technology...prostate cancer grows in the peripheral zones of the prostate...I'd worry about rupturing the prostate or even worse, potentially injuring structures right outside of the prostate and adjacent to the prostate, specifically the rectum...They're going to get the prostate cancer coding and approval. I think the adoption of it will be different...If you're removing BPH tissue, you're going to see a reduction in PSA score, which you're going to say, 'Oh, the prostate cancer was treated well,' when it might not have been...I think from a logical perspective, it does not make sense to use Aquablation for prostate cancer or focal therapy for prostate cancer.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7fd8e490-8f6c-4b29-beda-2dab2f088c14",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.74,
        "x": 0.25,
        "y": 0.64
      },
      "kind": "quote",
      "text": "They're competing against focal therapy platforms such as Sonablate, such as Focal One. Those platforms that they're going to be competing with were originally designed for prostate cancer and are now moving on to the additional BPH. Those therapies were done for prostate cancer and now will get coding to bill for BPH during the procedure. You can do two procedures where you make essentially 1.5X one of those procedures.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d677ebf-6856-4b75-a32a-af3d8da6879a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I think it's tricky with their technology...prostate cancer grows in the peripheral zones of the prostate...I'd worry about rupturing the prostate or even worse, potentially injuring structures right outside of the prostate and adjacent to the prostate, specifically the rectum...I think from a logical perspective, it does not make sense to use Aquablation for prostate cancer or focal therapy for prostate cancer. — Tegus Interview with Private Practice Urologist, Dec 2024",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-ee36-760b-929b-8bc7ffae1f7c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.48,
        "x": 0.02,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Source: Tegus, EDAP press release, Profound Medical press release, Spruce Point research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d8055f9c-c636-4d5e-aa37-1a0f8729e46e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.31,
        "y": 0.03
      },
      "kind": "title",
      "text": "We Don't Believe Aquablation Is Well-Suited For Prostate Cancer Applications",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49ddafe2-4bc7-48d8-bffd-d7ffad857645",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "metaphor-analogy",
      "slug": null,
      "matchId": "4c7bc6d5-fbe8-403d-9ee5-6e271953b394",
      "evidence": "Prostate as an orange analogy",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}